CIK 0002035832 · <br>Emerging growth company
Aktis Oncology, Inc.
Sign in to watch- Ticker
- AKTS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 852584233
- Phone
- 978-237-4380
- Business address
- 17 DRYDOCK AVENUE, SUITE #17-401, BOSTON, MA, 02210
- DRS/A Other Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- UPLOAD Other SEC-generated Letter
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
Page 4 of 4 · 70 filings